Wednesday, September 25, 2019
- 1:15pm-2:45pm
-
Usefulness of Cardiac MIBG Scintigraphy, DAT scan and midbrain/pontine ratio to differentiate Parkinson disease from atypical parkinsonian syndrome
Neuroimaging · Les Muses Terrace, Level 3
- 1:15pm-2:45pm
-
Using Brain Atrophy and Visual Dysfunction to Predict Dementia in Parkinson’s Disease
Cognition and Cognitive Disorders · Agora 3 East, Level 3
- 1:15pm-2:45pm
-
Validation of a novel quotient differentiating cognitive and motor-driven activity of daily living impairments in PD patients
Cognition and Cognitive Disorders · Agora 3 East, Level 3
- 1:15pm-2:45pm
-
Validation of the ‘ecological momentary assessment’ (EMA) method as a tool for daily life monitoring in patients with Parkinson’s disease
Phenomenology and Clinical Assessment of Movement Disorders · Les Muses Terrace, Level 3
- 1:15pm-2:45pm
-
Validation of the Seoul-instrumental activity daily living in the detection of dementia in Parkinson disease
Cognition and Cognitive Disorders · Agora 3 East, Level 3
- 1:15pm-2:45pm
-
Variations in Olfactory Neural Connections Associated with Cognition in Parkinson’s Disease
Neuroimaging · Les Muses Terrace, Level 3
- 1:15pm-2:45pm
-
Vascular risk factors, WMLs and the risk of cognitive impairment in Parkinson disease: A longitudinal study from the Parkinson’s Disease Cognitive Impairment Study (PaCoS) cohort
Cognition and Cognitive Disorders · Agora 3 East, Level 3
- 1:15pm-2:45pm
-
Vascular white matter involvement in Idiopathic Normal Pressure Hydrocephalus: association with cognitive and motor impairment
Cognition and Cognitive Disorders · Agora 3 East, Level 3
- 1:15pm-2:45pm
-
Verbal Disfluencies in Parkinson´s Disease Spoken Discourse as a Function of Syntax Complexity
Cognition and Cognitive Disorders · Agora 3 East, Level 3
- 1:15pm-2:45pm
-
VIM stimulation for refractory tremor -the Sheba experience
Surgical Therapy · Les Muses Terrace, Level 3